Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
暂无分享,去创建一个
[1] L. Serrano,et al. Sequence determinants of amyloid fibril formation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[3] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[4] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] Christopher M. Dobson,et al. Protein-misfolding diseases: Getting out of shape , 2002, Nature.
[6] R. Samudrala. Faculty Opinions recommendation of Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. , 2002 .
[7] L. Serrano,et al. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. , 2002, Journal of molecular biology.
[8] C. Dobson,et al. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme , 2002, Nature Structural Biology.
[9] Christopher M. Dobson,et al. Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.
[10] Christopher M Dobson,et al. Getting out of shape. , 2002, Nature.
[11] C Redfield,et al. Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy , 2001, Protein science : a publication of the Protein Society.
[12] J. Kelly,et al. Trans-Suppression of Misfolding in an Amyloid Disease , 2001, Science.
[13] L Serrano,et al. Computer-aided design of beta-sheet peptides. , 2001, Journal of molecular biology.
[14] S. Younkin,et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.
[15] C. Dobson. The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[16] V. Shnyrov,et al. Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin. , 2000, Biophysical chemistry.
[17] C. Dobson,et al. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. , 2000, Journal of structural biology.
[18] M. Saraiva,et al. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M. , 2000, Biochemical and biophysical research communications.
[19] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[20] L Serrano,et al. Elucidating the folding problem of alpha-helices: local motifs, long-range electrostatics, ionic-strength dependence and prediction of NMR parameters. , 1998, Journal of molecular biology.
[21] R. Brito,et al. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution , 1997, FEBS letters.
[22] L Serrano,et al. Role of beta-turn residues in beta-hairpin formation and stability in designed peptides. , 1997, Journal of molecular biology.
[23] R. L. Baldwin,et al. Mechanism of helix induction by trifluoroethanol: a framework for extrapolating the helix-forming properties of peptides from trifluoroethanol/water mixtures back to water. , 1997, Biochemistry.
[24] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[25] H. Naiki,et al. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[26] J. Kelly,et al. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. , 1995, Biochemistry.
[27] L Serrano,et al. Folding of protein G B1 domain studied by the conformational characterization of fragments comprising its secondary structure elements. , 1995, European journal of biochemistry.
[28] D. Booth,et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis , 1993, Nature.
[29] B. Matthews. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.